Acknowledgements
CHUV, Claudia
ALLERGY, ALMEIDA, TAPIA
This work was sponsored and funded by We thank all the volunteers for their participation in this trial. We thank Alisa De Almeida, Yoanne Boulez, Sara Mantero, and Marc Froissart, from the Clinical Trial Unit of the Centre Hospitalier Universitaire Vaudois (CHUV), Benoit Kopp, research physician; Serge de Vallière, principal investigator substitute, Aline Voidey, Akram Farhat and Isabelle Sommer, CHUV pharmacists, for the randomization and preparation of the vaccine doses; Anne Niquille for the unblinding procedure, Gonzalo Tapia, Claudia Lima, Silvia Sabatino and the VIC team (Immunology and Allergy, CHUV) for the preparation of sera and PBMCs, Curdin Conrad and Yannick Muller for their clinical expertise, Giovanna Bonsembiante for administrative assistance, Eric Huber, Elizabeth Reuss and Sandro Schmidlin from the Swiss Tropical and Public Health Institute for monitoring; Pierre Landry, Thierry Buclin, Laura Rothuizen, and Paul Milligan—as members of the Data and Safety Monitoring Committee.Supplementary data related to this article can be found at 